
New Strategies for Medtech Startups: Attracting Investment from Across the Innovation Ecosystem
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.

Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.

To understand where medtech companies stand in fulfilling this objective, Deloitte and AdvaMed® conducted a benchmarking analysis of data from 20 medtech company business units.

Dr. Anula Jayasuriya, an MD, PhD, and MBA from Harvard, is a leading venture capital executive focusing on investing in women’s health. Through EXXclaim Capital, a venture fund she founded…
WASHINGTON, D.C. – AdvaMed Accel® – the division within AdvaMed® dedicated to addressing the unique needs and challenges of smaller medical technology manufacturers – announced that Martha Shadan, executive chairwoman…